Mgr. Marek Borský
Researcher, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 4830 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 118
2016
-
Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis
Blood, year: 2016, volume: 128, edition: 12, DOI
-
Ibrutinib inhibits CD20 up-regulation on CLL B cells mediated by the CXCR4/SDF-1 AXIS.
Year: 2016, type: Conference abstract
-
Interakce B lymfocytů s mikroprostředím vedou ke zvýšené expresi CD20 přes aktivaci dráhy CXCR4/SDF-1: význam pro léčbu pacientů s B buněčnou leukémií.
Year: 2016, type: Conference abstract
-
Nová kombinace antigenů vhodná pro sledování minimální reziduální nemoci u vlasatobuněčné leukemie metodou průtokové cytometrie.
Year: 2016, type: Conference abstract
-
Quantitative assessment of the CD26+leukemic stem cell compartment in chronic myeloid leukemia: Patient-subgroups, prognostic impact, and technical aspects
Oncotarget, year: 2016, volume: 7, edition: 22, DOI
-
Rituximab preferentially eliminates BCR signaling proficient chronic lymphocytic leukemia B cells In Vivo
Year: 2016, type: Conference abstract
-
Single cell analysis of clonality in chronic lymphocytic leukemia patients with multiple immunoglobulin gene rearrangement.
Year: 2016, type: Conference abstract
-
Studium klonální kompozice chronické lymfocytární leukemie s vícečetnými imunoglobulinovými přestavbami na úrovni jednotlivých buněk.
Year: 2016, type: Conference abstract
-
The expression of CD20 on malignant B cells is regulated by chemokine signaling through the CXCR4/SDF1 axis: implications for targeting the microenvironmental interactions.
Year: 2016, type: Conference abstract